Potential effects of corticosteroids on physiological dead-space fraction in acute respiratory distress syndrome

Respiratory Care

Volumn 57, Issue 3, 2012, Pages 377-383

  Raurich, Joan M ^a   Ferreruela, Mireia ^a   Llompart Pou, Juan A ^a   Vilar, Margalida ^a   Colomar, Asunción ^a   Ayestarán, Ignacio ^a   Pérez Bárcena, Jon ^a   Ibáñez, Jordi ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Acute respiratory distress syndrome; ARDS; Corticosteroids; Dead space; Mechanical ventilation; Methylprednisolone

Indexed keywords

METHYLPREDNISOLONE; GLUCOCORTICOID;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; LUNG COMPLIANCE; LUNG DEAD SPACE; LUNG FUNCTION; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN TENSION; OXYGENATION; PHYSIOLOGICAL PROCESS; POSITIVE END EXPIRATORY PRESSURE; PRESSURE MEASUREMENT; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIDAL VOLUME; TIME;

ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY DEAD SPACE; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; TIDAL VOLUME; TIME FACTORS;

EID: 84859482775     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01301     Document Type: Article

References (29)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-1349.
3. Coffey RL, Albert RK, Robertson HT. Mechanisms of physiological dead space response to PEEP after acute oleic acid lung injury. J Appl Physiol 1983;55(5):1550-1557.
4. Greene R, Zapol WM, Snider MT, Reid L, Snow R, O'Connell RS, Novelline RA. Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 1981; 124(5):593-601.
5. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002;346(17):1281-1286.
6. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991;100(4):943-952.
7. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome N Engl J Med 2006;354(16):1671-1684.
8. Cepkova M, Kapur V, Ren X, Quinn T, Zhuo H, Foster E, et al. Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. Chest 2007;132(3):836-842.
9. Kallet RH, Alonso JA, Pittet JF, Matthay MA. Prognostic value of he pulmonary dead-space fraction during the first 6 days of acute respiratory distress syndrome. Respir Care 2004;49(9):1008-1014.
10. Gattinoni L, Carlesso E, Cressoni M. Assessing gas exchange in acute lung injury/acute respiratory distress syndrome: diagnostic techniques and prognostic relevance. Curr Opin Crit Care 2011;17(1): 18-23.
11. Raurich JM, Vilar M, Colomar A, Ibáñez J, Ayestarán I, PérezBárcena J, Llompart-Pou JA. Prognostic value of the pulmonary dead-space fraction during the early and intermediate phases of acute respiratory distress syndrome. Respir Care 2010;55(3):282-287.
12. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995;152(6):1818-1824.
13. Ware LB. Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005; 33(3 Suppl):S217-S222.
14. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998;158(4):1076-1081.
15. Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD, Rubenfeld GD. Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 2008;36(5):1412-1420.
16. Seeley E, McAuley DF, Eisner M, Miletin M, Matthay MA, Kallet RH. Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax 2008;63(11):994-998.
17. Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010;181(10):1121-1127.
18. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280(2):159-165.
19. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178(6): 618-623.
20. Kallet RH, Jasmer RM, Pittet JF. Alveolar dead-space response to activated protein C in acute respiratory distress syndrome. Respir Care 2010;55(5):617-622.
21. Rossi A, Polese G, Milic-Emili J. Monitoring respiratory mechanics in ventilator-dependent patients. In: Tobin MJ, editor. Principles and practice of intensive care monitoring. New York: McGraw-Hill; 1998: 553-596.
22. Crossman PF, Bushnell LS, Hedley-Whyte J. Dead space during artificial ventilation: gas compression and mechanical dead space. J Appl Physiol 1970;28(1):94-97.
23. Forbat AF, Her C. Correction for gas compression in mechanical ventilators. Anesth Analg 1980;59(7):488-493.
24. Enghoff H. Volumen inefficax: Bemerkungen zur Frage des schädlichen Raumes. Upsala Lakareforen Forh 1938;44:191-218. Article in German.
25. Le Gall Jr, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270(24):2957-2963.
26. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707-710.
27. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138(3):720-723.
28. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37(5):1594-1603.
29. Sessler CN, Gay PC. Are corticosteroids useful in late-stage acute respiratory distress syndrome? Respir Care 2010;55(1):43-55.